Skip to main content
. 2018 Jan 2;20:1. doi: 10.1186/s13058-017-0925-3

Table 2.

Selected single-nucleotide polymorphisms in relation to vitamin D level and breast cancer

SNP (GWAS SNP) Risk of low vitamin D Risk of breast cancer
Allele Frequency of low/high vitamin Da (n = 1343) Crude OR of low vitamin D (95% CI) Adjusted ORb of low vitamin D (95% CI) Cases/control subjects (n = 4058) Crude OR (95% CI) Adjusted ORb (95% CI)
rs12239582 (rs12144344)
 CC 224/188 1.00 1.00 290/986 1.00 1.00
 CA 344/336 0.86 (0.67–1.10) 0.87 (0.67–1.12) 412/1604 0.87 (0.74–1.04) 0.82 (0.68–0.99)
 AA 116/135 0.72 (0.53–0.99) 0.72 (0.52–1.00) 163/600 0.92 (0.74–1.15) 0.93 (0.73–1.17)
 Missing 0/3
rs705117
 CC 504/486 1.00 1.00 657/2376 1.00 1.00
 CT 164/168 0.94 (0.73–1.21) 0.94 (0.73–1.22) 194/762 0.92 (0.77–1.10) 0.86 (0.71–1.05)
 TT 16/5 3.06 (1.11–8.44) 3.38 (1.20–9.49) 14/55 0.92 (0.51–1.67) 0.94 (0.49–1.81)
rs7041
 AA 213/270 1.00 1.00 332/1149 1.00 1.00
 AC 341/308 1.40 (1.11–1.78) 1.39 (1.09–1.77) 397/1521 0.90 (0.77–1.07) 0.88 (0.74–1.05)
 CC 130/81 2.03 (1.46–2.83) 2.12 (1.51–2.99) 136/522 0.90 (0.72–1.13) 0.89 (0.70–1.13)
 Missing 0/1
rs2282679 (rs17467825)
 GG 342/397 1.00 1.00 480/1734 1.00 1.00
 GT 278/230 1.40 (1.12–1.76) 1.42 (1.13–1.80) 326/1222 0.96 (0.82–1.13) 0.98 (0.83–1.16)
 TT 62/29 2.45 (1.56–3.95) 2.51 (1.56–4.05) 57/229 0.90 (0.66–1.22) 0.91 (0.66–1.27)
 Missing 2/3 2/8
rs10485165
 TT 515/501 1.00 1.00 650/2385 1.00 1.00
 TC 153/144 1.04 (0.80–1.35) 1.03 (0.79–1.34) 194/735 0.97 (0.81–1.16) 0.99 (0.82–1.20)
 CC 16/14 1.10 (0.53–2.29) 1.04 (0.49–2.21) 21/73 1.06 (0.65–1.73) 1.00 (0.60–1.74)
rs198300 (rs156299)
 GG 218/229 1.00 1.00 295/1134 1.00 1.00
 GA 344/319 1.13 (0.89–1.44) 1.08 (0.84–1.38) 430/1513 1.09 (0.92–1.29) 1.10 (0.91–1.30)
 AA 122/111 1.16 (0.84–1.59) 1.09 (0.79–1.52) 140/545 0.99 (0.79–1.24) 0.96 (0.75–1.22)
 Missing 0/1
rs4751058
 AA 496/460 1.00 1.00 614/2286 1.00 1.00
 AG 174/183 0.88 (0.69–1.13) 0.88 (0.68–1.13) 234/828 1.05 (0.89–1.25) 1.05 (0.88–1.27)
 GG 14/16 0.81 (0.39–1.68) 0.77 (0.36–1.63) 17/79 0.80 (0.47–1.36) 0.66 (0.38–1.17)
rs12295888 (rs12287212)
 CC 270/296 1.00 1.00 367/1384 1.00 1.00
 CT 321/302 1.16 (0.93–1.46) 1.22 (0.96–1.54) 402/1435 1.06 (0.90–1.24) 1.05 (0.88–1.24)
 TT 93/61 1.67 (1.16–2.40) 1.80 (1.24–2.63) 96/373 0.97 (0.75–1.25) 0.93 (0.71–1.23)
 Missing 0/1
rs1007392
 GG 231/267 1.00 1.00 325/1184 1.00 1.00
 GA 337/310 1.26 (0.99–1.59) 1.31 (1.03–1.67) 417/1543 0.99 (0.84–1.16) 0.99 (0.83–1.18)
 AA 115/82 1.62 (1.16–2.26) 1.78 (1.26–2.52) 123/462 0.97 (0.77–1.23) 0.91 (0.71–1.17)
 Missing 1/0 0/4
rs2060793 (rs10741657)
 AA 246/194 1.00 1.00 283/1040 1.00 1.00
 AG 328/323 0.80 (0.63–1.02) 0.78 (0.61–1.00) 418/1544 1.00 (0.84–1.18) 1.10 (0.92–1.33)
 GG 110/142 0.61 (0.45–0.84) 0.58 (0.42–0.81) 164/606 1.00 (0.80–1.24) 1.04 (0.82–1.32)
 Missing 0/3
rs7944926 (rs12785878)
 AA 297/343 1.00 1.00 423/1436 1.00 1.00
 AG 299/272 1.27 (1.01–1.59) 1.30 (1.03–1.64) 366/1400 0.89 (0.76–1.04) 0.91 (0.77–1.08)
 GG 88/44 2.31 (1.56–3.43) 2.39 (1.59–3.59) 76/356 0.73 (0.55–0.95) 0.77 (0.57–1.02)
 Missing 0/1
rs3829251
 AA 402/435 1.00 1.00 545/1954 1.00 1.00
 AG 242/210 1.25 (0.99–1.57) 1.30 (1.02–1.64) 287/1079 0.95 (0.81–1.12) 0.99 (0.83–1.18)
 GG 40/14 3.09 (1.65–5.77) 3.26 (1.72–6.17) 33/160 0.74(0.50–1.09) 0.77 (0.51–1.16)
rs2302190
 CC 451/466 1.00 1.00 566/2122 1.00 1.00
 CT 211/176 1.24 (0.98–1.57) 1.24 (0.97–1.58) 268/955 1.05(0.89–1.24) 1.09 (0.91–1.30)
 TT 20/13 1.59 (0.78–3.23) 1.45 (0.69–3.02) 28/109 0.96 (0.63–1.47) 0.99 (0.62–1.58)
 Missing 2/4 3/7

GWAS Genome-wide association study, SNP Single-nucleotide polymorphism

aLow vs high vitamin D grouped by calendar month

bAdjusted for age at baseline, year of inclusion, level of education, type of occupation, age at menarche, age at first childbirth, exposure to oral contraceptives, exposure to hormone replacement therapy, height, body mass index, alcohol consumption and smoking